# Brexpiprazole for Bipolar Depression

> **NCT03427892** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Brexpiprazole

## Key facts

- **NCT ID:** NCT03427892
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-03-15
- **Final completion:** 2018-03-15
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427892, "Brexpiprazole for Bipolar Depression". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03427892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*